Use of Corifolitropin Alfa in Oocyte Donors

• Status: Unknown status
• Trial end date: 2015-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine if corifollitropin alfa (long-term gonadotropin administration) is effective in a controlled ovarian stimulation protocol in oocyte donors compared to daily gonadotropin administration (recombinant FSH or HP-hMG)

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: IVI Madrid
• Collaborators: Instituto Valenciano de Infertilidad, IVI Alicante; Instituto Valenciano de Infertilidad, IVI VALENCIA
• Treatments: Menotropins

Criteria

Inclusion Criteria:

• Women aged 18-35 years who meet the entry criteria for the IVI Donor Program:

• Weight < 60 Kg

• Women with at least 6 antral follicles per ovary

• Women who will fit the protocoo during the period of the study

• Women who give written consent to participate in the test

Exclusion Criteria:

• Women with basal antral follicle count above 20 or below 6.

• Women with comorbidities, in the judgement of the investigator, that may interfere with the trearment of ovarian stimulation.